FDA Drug recall D-0853-2017
Fentanyl Citrate and Bupivacaine HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
- FDA Drug
- Class II
- terminated
- Published 2017-05-31
On 2017-05-31 the FDA classified a Class II recall of Fentanyl Citrate and Bupivacaine HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054 by Advanced Pharma, citing labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0853-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2017-02-22 |
| Published | 2017-05-31 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Advanced Pharma |
| Distribution | US |
Product
Fentanyl Citrate and Bupivacaine HCl all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054
Reason
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Identifiers
| code_info | all lots within expiry. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0853-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.